BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18956236)

  • 1. A systematic review of the effects of disclosing carrier results generated through newborn screening.
    Hayeems RZ; Bytautas JP; Miller FA
    J Genet Couns; 2008 Dec; 17(6):538-49. PubMed ID: 18956236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening.
    Ulph F; Cullinan T; Qureshi N; Kai J
    Eur J Hum Genet; 2015 Apr; 23(4):459-65. PubMed ID: 25005733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parents' Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease.
    Chudleigh J; Buckingham S; Dignan J; O'Driscoll S; Johnson K; Rees D; Wyatt H; Metcalfe A
    J Genet Couns; 2016 Dec; 25(6):1215-1226. PubMed ID: 27098418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes of genetic counselors towards expanding newborn screening and offering predictive genetic testing to children.
    Hiraki S; Ormond KE; Kim K; Ross LF
    Am J Med Genet A; 2006 Nov; 140(21):2312-9. PubMed ID: 17036312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status.
    Farrell MH; La Pean Kirschner A; Tluczek A; Farrell PM
    J Pediatr; 2020 Sep; 224():37-43.e2. PubMed ID: 32386871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell and cystic fibrosis carrier results.
    Nurs Child Young People; 2016 Oct; 28(8):21. PubMed ID: 27712319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis.
    Stark AP; Lang CW; Ross LF
    Am J Perinatol; 2011 Mar; 28(3):169-76. PubMed ID: 20830657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
    Kai J; Ulph F; Cullinan T; Qureshi N
    Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier screening for cystic fibrosis.
    Massie J
    Lancet; 2009 Sep; 374(9694):978. PubMed ID: 19766881
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of high-quality communication behaviors used by primary care providers of heterozygous infants after newborn screening.
    Farrell MH; Christopher SA
    Patient Educ Couns; 2013 Feb; 90(2):226-32. PubMed ID: 23194821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.
    Bombard Y; Miller FA; Barg CJ; Patton SJ; Carroll JC; Chakraborty P; Potter BK; Tam K; Taylor L; Kerr E; Davies C; Milburn J; Ratjen F; Guttmann A; Hayeems RZ
    Genet Med; 2017 Apr; 19(4):403-411. PubMed ID: 27608173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Parental Understanding of Positive Newborn Screening Results and Carrier Status for Cystic Fibrosis with the use of a Short Educational Video.
    Temme R; Gruber A; Johnson M; Read L; Lu Y; McNamara J
    J Genet Couns; 2015 Jun; 24(3):473-81. PubMed ID: 25236483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening.
    Lewis S; Curnow L; Ross M; Massie J
    J Paediatr Child Health; 2006 Sep; 42(9):533-7. PubMed ID: 16925540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis.
    Vernooij-van Langen AM; Reijntjens S; van der Pal SM; Loeber JG; Dompeling E; Dankert-Roelse JE
    Eur J Med Genet; 2013 Apr; 56(4):192-6. PubMed ID: 23352994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening: an appeal for improved parent education.
    Tluczek A; Orland KM; Nick SW; Brown RL
    J Perinat Neonatal Nurs; 2009; 23(4):326-34. PubMed ID: 19915416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and beliefs of pediatricians and genetic counselors regarding testing and screening for CF and G6PD: implications for policy.
    Koopmans J; Hiraki S; Ross LF
    Am J Med Genet A; 2006 Nov; 140(21):2305-11. PubMed ID: 17022079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.
    McClaren BJ; Metcalfe SA; Aitken M; Massie RJ; Ukoumunne OC; Amor DJ
    Eur J Hum Genet; 2010 Oct; 18(10):1084-9. PubMed ID: 20512163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A re-examination of the use of ethnicity in prenatal carrier testing.
    Ross LF
    Am J Med Genet A; 2012 Jan; 158A(1):19-23. PubMed ID: 22106058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings.
    Leppert K; Bisordi K; Nieto J; Maloney K; Guan Y; Dixon S; Egense A
    J Genet Couns; 2018 Dec; 27(6):1328-1340. PubMed ID: 29687313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.